COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey.

Singer, A J; Fuggle, N R; Gill, C B; Patel, A R; Medeiros, A P; Greenspan, S L

Singer, A J; Fuggle, N R; Gill, C B; Patel, A R; Medeiros, A P; Greenspan, S L.

Afiliación

Singer AJ; Departments of Medicine and Obstetrics and Gynecology, MedStar Georgetown University Hospital and Georgetown University Medical Center, Washington, DC, USA. andrea.f.singer@gunet.georgetown.edu.
Fuggle NR; Department of Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, DC, USA. andrea.f.singer@gunet.georgetown.edu.
Gill CB; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
Patel AR; Alan Turing Institute, London, UK.
Medeiros AP; National Osteoporosis Foundation, Arlington, VA, USA.
Greenspan SL; National Osteoporosis Foundation, Arlington, VA, USA.

Osteoporos Int ; 32(4): 619-622, 2021 04.

Article en En | MEDLINE | ID: mdl-33558958

Asunto(s)

COVID-19; Osteoporosis; Humanos; Osteoporosis/tratamiento farmacológico; SARS-CoV-2

Palabras clave

Bone health; COVID-19; Fracture; Osteoporosis; Telemedicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / COVID-19 Límite: Humans Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google